David Giroux is an Associate in the Complex Commercial Litigation Department of Kaye Scholer’s New York office. David’s practice focuses primarily on pharmaceutical products liability litigation, general commercial litigation, breach of contract actions and FDA regulatory compliance.
David has experience at all stages of litigation. He has defended major pharmaceutical manufacturers in multiple state and federal failure-to-warn cases, advised clients in commercial and employment contractual matters, and counseled on litigation and regulatory considerations related to proposed acquisitions. David has also provided regulatory compliance guidance to pharmaceutical manufacturers, particularly related to FDA adverse event reporting requirements and anti-kickback concerns. He recently conducted an internal compliance audit for a major pharmaceutical company.
David has an active pro bono practice at Kaye Scholer. He represented state judges challenging a Kansas law that stripped the Kansas Supreme Court of its constitutional authority to administer the state’s unified court system. David also defended the City of New York against constitutional tort, wrongful death, and medical malpractice claims. In addition, he has represented clients seeking child support modifications and clients seeking Social Security disability benefits.
David received his JD from the New York University School of Law. While at NYU Law, David served as the Symposium Editor for the NYU Annual Survey of American Law, overseeing the journal’s symposium “The Continuing Vitality of Unions.” He also participated in the law school’s Civil Rights Clinic.
In The Market
- Following Five-Day Trial, Kaye Scholer Secures Win for Medicalgorithmics August 25, 2016 • Client Successes
- Judge Grants Pfizer’s Motion for Summary Judgment in Zoloft MDL April 7, 2016 • Client Successes
- Kaye Scholer Pro Bono Efforts Help Preserve Kansas’ Independent Judiciary January 4, 2016 • Client Successes